[1]Garcia-Alvarez A, Papakonstantinou A, Oliveira M. Brain Metastases in HER2-Positive Breast Cancer: Current and Novel Treatment Strategies. Cancers (Basel). 2021 Jun 11;13(12):2927. [2]Lin N.U., Amiri-Kordestani L., Palmieri D., et al. CNS metastases in breast cancer: old challeng...
[4] Garcia-Alvarez A, Papakonstantinou A, Oliveira M. Brain Metastases in HER2-Positive Breast Cancer: Current and Novel Treatment Strategies. Cancers (Basel). 2021 Jun 11;13(12):2927. [5] Gion M, Trapani D, Cortés A, et al. Systemic Therapy for HER2-Positive Metastatic Breast Cancer: ...
[4] Garcia-Alvarez A, Papakonstantinou A, Oliveira M. Brain Metastases in HER2-Positive Breast Cancer: Current and Novel Treatment Strategies. Cancers (Basel). 2021 Jun 11;13(12):2927. [5] Gion M, Trapani D, Cortés A, et al. Systemic...
[8] Wong Y, Raghavendra AS, Hatzis C, et al. Long-Term Survival of De Novo Stage IV Human Epidermal Growth Receptor 2 (HER2) Positive Breast Cancers Treated with HER2-Targeted Therapy. Oncologist. 2019 Mar;24(3):313-318. [9] Verma S, et al. Trastuzumab emtansine for HER2-positive ad...
[6]Garcia-Alvarez A, Papakonstantinou A, Oliveira M. Brain Metastases in HER2-Positive Breast Cancer: Current and Novel Treatment Strategies. Cancers (Basel). 2021 Jun 11;13(12):2927. [7] Brufsky AM, Mayer M, Rugo HS...
[5] Wong Y, Raghavendra AS, Hatzis C, et al. Long-Term Survival of De Novo Stage IV Human Epidermal Growth Receptor 2 (HER2) Positive Breast Cancers Treated with HER2-Targeted Therapy. Oncologist. 2019;24(3):313-318. doi:10.1634/theoncologist.2018-0213 ...
在2023年4月,《Arch Pathol Lab Med》杂志上,Gary Tozbikian等人发表了一篇名为《Emerging Landscape of Targeted Therapy of Breast Cancers With Low HER2 Protein Expression》的综述文章。这篇文章从病理学家的视角出发,探讨了HER2低表达在乳腺癌靶向治疗中的新动态。文章的核心内容涵盖了以下几个方面: ...
[3]Nami B, Maadi H, Wang Z. Mechanisms underlying the action and synergism of trastuzumab and pertuzumab in targeting HER2-positive breast cancer. Cancers 2018; 10 (10): 342[J].[4]《乳腺癌HER2检测指南(2019版)》编写组.乳腺癌HER2检测指南(2019版)[J].中华病理学杂志, 2019, 048(003):169-...
[5] Baez-Vallecillo L, Raghavendra AS, Hess KR, et al. Lapatinib activity in metastatic human epidermal growth factor receptor 2-positive breast cancers that received prior therapy with trastuzumab, pertuzumab, and/or ado-trastuzumab emtansine (T-DM1). Breast Cancer Res Treat 2019;176(1):227...
[6]Garcia-Alvarez A, Papakonstantinou A, Oliveira M. Brain Metastases in HER2-Positive Breast Cancer: Current and Novel Treatment Strategies. Cancers (Basel). 2021 Jun 11;13(12):2927. [7] Brufsky AM, Mayer M, Rugo HS, et al. Central nervous system metastases in patients with HER2-...